A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
about
Large animal models of cardiovascular diseaseRestoration of bone mineralization by cinacalcet is associated with a significant reduction in calcitriol-induced vascular calcification in uremic ratsCalcimimetic R-568 and its enantiomer S-568 increase nitric oxide release in human endothelial cellsCalcium-sensing receptor biosynthesis includes a cotranslational conformational checkpoint and endoplasmic reticulum retentionThe calcium-sensing receptor and calcimimetics in blood pressure modulationThe Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.Elimination of vitamin D receptor in vascular endothelial cells alters vascular functionNew concepts in calcium-sensing receptor pharmacology and signallingHigh salt intake causes adverse fetal programming--vascular effects beyond blood pressureEnhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.Decreased transcriptional activity of calcium-sensing receptor gene promoter 1 is associated with calcium nephrolithiasis.Phosphate: an old bone molecule but new cardiovascular risk factor.A new role for vitamin D receptor activation in chronic kidney disease.Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders.Vitamin D and vascular calcification in chronic kidney disease.Vascular and valvular calcification in chronic peritoneal dialysis patients.Pharmacotherapy of chronic kidney disease and mineral bone disorder.Plant polyphenols in the treatment of age-associated diseases: revealing the pleiotropic effects of icariin by network analysis.The calcium sensing receptor: from calcium sensing to signaling.The Use of Calcimimetics for the Treatment of Secondary Hyperparathyroidism: A 10 Year Evidence Review.Vascular Calcification in Uremia: New-Age Concepts about an Old-Age Problem.Calcimimetics and outcomes in CKD.Diagnosis of Arterial Media Calcification in Chronic Kidney Disease.Endothelin A receptor blocker and calcimimetic in the adenine rat model of chronic renal insufficiency.The calcimimetic AMG 641 accelerates regression of extraosseous calcification in uremic rats.Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism.Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action.The calcimimetic R-568 prevents podocyte loss in uninephrectomized ApoE-/- mice.Calcimimetic R-568 vasodilatory effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs)
P2860
Q26766350-234B9DA0-AE6D-4338-B5E5-36AE35C4BB76Q28569272-F901ECEC-D2D2-48DA-B143-9F94F9543E47Q28732422-4A98A8BD-96C9-4298-B2DE-AC4F6A5CFE0BQ33924278-18D7F6F5-D0C9-4825-82BD-B99210DB40A3Q35376000-C83D9E4B-9D4F-4717-8F74-384D30513AADQ35576108-9C111F8B-9C96-4BF4-A62B-F5A0E2120D0EQ35601964-90D766C3-E934-405C-80FC-9454E8AD31F5Q35657894-AAAA34AD-39AF-4282-9F0D-3D0E009EE1D3Q36208577-54B69A24-0192-44F4-9E91-CBA816DDB7C6Q36963124-DA340C5C-F4D8-42A4-A08A-90C68CB4C689Q37149612-2C9660B2-AE62-46D6-989E-1100F8DF62B0Q37492019-4DBD935F-0325-4214-B417-59CE39E100BEQ37558961-5088D2EE-13A0-4E09-9962-9631F0DA23ACQ37635257-CBBCF479-029D-4989-AC32-17E8B33612D9Q37892311-81DE8650-6C09-4D1C-81B7-F012ED5CCD96Q37914009-92933328-CF90-4013-AC76-E093E0C1F344Q37948105-31C5C289-7B0D-4AE8-8F32-497CD5D2915BQ38169127-0FA83EAD-C41E-4545-AB9D-8BC1F4DBDBE1Q38313467-B836CC75-948C-481E-8EC5-313FEDDEA2DDQ38370743-34EDE7F2-6124-4CC7-8146-A861B7493FAFQ38671493-D5253DD1-ABAE-46FE-A02F-C766C538D884Q42727545-056EA1F1-2190-48BC-A93A-6A542FBB5F6CQ43077637-B79BDA11-B202-4E3A-9148-1D2AD7D69223Q43237868-4CDA4174-1296-4795-914D-82722C85DB3EQ46074765-244FDE65-FD10-4CB9-ABFE-E5C08304550EQ50077724-2A2AA875-B170-4F6A-8DBB-F8945DCB20A0Q50483584-DFDD4932-3D2E-42BD-BE42-1321BF81728CQ50970292-2D03A471-D4B9-4C98-91F3-213F46E9760DQ58229695-8B6A8F74-E2D4-4CCF-8CD8-CE4368875759
P2860
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
description
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2009
@ast
im Januar 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2009/01/01)
@sk
vědecký článek publikovaný v roce 2009
@cs
wetenschappelijk artikel (gepubliceerd op 2009/01/01)
@nl
наукова стаття, опублікована в січні 2009
@uk
مقالة علمية (نشرت عام 2009)
@ar
name
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
@ast
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
@en
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
@nl
type
label
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
@ast
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
@en
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
@nl
prefLabel
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
@ast
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
@en
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
@nl
P2093
P356
P1433
P1476
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
@en
P2093
Claus Peter Schmitt
Eberhard Ritz
Marie-Luise Gross
Nadezda Koleganova
P2888
P356
10.1038/KI.2008.490
P407
P577
2008-10-01T00:00:00Z
P5875
P6179
1049677107